Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: New insights into the working mechanism of antimuscarinics

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Neurourology and Urodynamics

• Publication date

  2006-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/nau.20208PMID 16372316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways.

  2005cited by this paper
• The urothelium in overactive bladder: passive bystander or active participant?

  2004cited by this paper
• Urinary bladder contraction and relaxation: physiology and pathophysiology.

  2004cited by this paper
• Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging.

  2004cited by this paper
• The urothelium in overactive bladder: Passive bystander or active participant?

  2004cited by this paper
• Antimuscarinics for treatment of overactive bladder.

  2004influential reference
• Intravesical oxybutynin: a local anesthetic effect on bladder C afferents.

  2003cited by this paper
• Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium.

  2003cited by this paper
• Clinical Pharmacokinetics of Drugs Used to Treat Urge Incontinence

  2003cited by this paper
• Effect of muscarinic antagonists on micturition pressure measured by cystometry in normal, conscious rats.

  2002influential reference
• Muscarinic receptor subtypes and management of the overactive bladder.

  2002cited by this paper
• P2X3 Knock-Out Mice Reveal a Major Sensory Role for Urothelially Released ATP

  2001cited by this paper
• Effect of anesthetics on reflex micturition in the chronic cannula‐implanted rat

  2000influential reference
• Urothelium‐derived inhibitory factor(s) influences on detrusor muscle contractility in vitro

  2000cited by this paper
• ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes–possible sensory mechanism?

  1997cited by this paper
• Neural Control of the Lower Urinary Tract

  1997cited by this paper
• Load-Insensitive Measurements from an Isolated Perfused Biventricular Working Rat Heart.

  1997cited by this paper
• Analysis of pressure/flow characteristics in the female rat and their pharmacologic modulation

  1996cited by this paper
• Oxybutynin

  1995cited by this paper
• Urine storage mechanisms.

  1995cited by this paper
• Mechanosensitive properties of pelvic nerve afferent fibers innervating the urinary bladder of the rat.

  1994influential reference
• The anticholinergic activity of agents indicated for urinary incontinence is an important property for effective control of bladder dysfunction.

  1989cited by this paper
• R and S enantiomers of oxybutynin: pharmacological effects in guinea pig bladder and intestine.

  1988cited by this paper
• Dissociation of urinary kallikrein activity and salt and water excretion in the rat.

  1986cited by this paper

• Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including β3-Adrenoceptor Agonists -Basic Research Perspectives-

  2024cites this paper
• Treating Lower Urinary Tract Symptoms in Older Adults: Intravesical Options

  2023cites this paper
• Evaluation of Choline and Acetylcholine Levels in Responders and Nonresponders to Anticholinergic Therapy for Overactive Bladder Syndrome

  2020cites this paper
• TAS-303 Ameliorates Carbachol-Induced Detrusor Overactivity in Rats, Revealing Its Therapeutic Potential for Overactive Bladder

  2020cites this paper
• The Big Prostate

  2018cites this paper
• Best practice in the management of storage symptoms in male lower urinary tract symptoms: a review of the evidence base

  2018cites this paper
• PATHOPHYSIOLOGY, MECHANISM AND MANAGEMENT OF OVERACTIVE BLADDER SYNDROME-A REVIEW

  2018cites this paper
• Medical Treatment of the Large Prostate

  2018cites this paper
• The efficacy of mirabegron in the treatment of urgency and the potential utility of combination therapy

  2018cites this paper
• Pathophysiology of Overactive Bladder: Current Understanding

  2017cites this paper
• Combinational effects of muscarinic receptor inhibition and β3‐adrenoceptor stimulation on neurogenic bladder dysfunction in rats with spinal cord injury

  2017cites this paper
• Combined treatment with a β3‐adrenergic receptor agonist and a muscarinic receptor antagonist inhibits detrusor overactivity induced by cold stress in spontaneously hypertensive rats

  2017cites this paper
• Combined low-dose antimuscarinics for refractory detrusor overactivity in children.

  2016cites this paper
• Morphological changes in the salivary acini after in vivo cholinergic stimulation

  2016cites this paper
• Oral medication for overactive bladder

  2015cites this paper
• Selective inhibitory effect of imidafenacin and 5-hydroxymethyl tolterodine on capsaicin sensitive C fibers of the primary bladder mechanosensitive afferent nerves in the rat.

  2015cites this paper
• Physiology of Urinary Continence

  2015cites this paper
• Structural and functional aspects of sensory-motor Interaction in the urinary bladder

  2015cites this paper
• Therapeutic targets for overactive bladder other than smooth muscle

  2015influential citation
• Solabegron: a potential future addition to the β-3 adrenoceptor agonist armamentarium for the management of overactive bladder

  2015cites this paper
• Investigating detrusor muscle concentrations of oxybutynin after intravesical delivery in an ex vivo porcine model.

  2015cites this paper
• Therapeutic modulation of urinary bladder function: multiple targets at multiple levels.

  2015cites this paper
• Urinary incontinence in the frail elderly: what do we still need to learn?

  2014cites this paper
• Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of “Overactive bladder”

  2014cites this paper
• Tolterodine extended release in the treatment of male oab/storage luts: a systematic review

  2014cites this paper
• New horizons: urinary incontinence in older people.

  2014cites this paper
• Etude de la sensibilité vésicale, des moyens d'évaluation et des possibles facteurs l'influençant

  2014cites this paper
• Current Pharmacologic Treatment of Lower Urinary Tract Symptoms

  2014cites this paper
• From urothelial signalling to experiencing a sensation related to the urinary bladder

  2013cites this paper
• Latest treatment for lower urinary tract dysfunction: Therapeutic agents and mechanism of action

  2013cites this paper
• Urothelial signaling.

  2013cites this paper
• Autonomic nervous control of the urinary bladder

  2013cites this paper
• Neurophysiology of Pelvic Pain Mechanisms

  2013cites this paper
• Fesoterodine, its active metabolite, and tolterodine bind selectively to muscarinic receptors in human bladder mucosa and detrusor muscle.

  2013cites this paper
• Chronic administration of anticholinergics in rats induces a shift from muscarinic to purinergic transmission in the bladder wall.

  2013cites this paper
• Contemporary Management of Overactive Bladder

  2012cites this paper
• Low‐Dose Anticholinergic Combination Therapy in Male Benign Prostatic Hyperplasia Patients with Overactive Bladder Symptoms

  2012cites this paper
• What do we really know about antimuscarinic therapy for adult neurogenic detrusor overactivity?

  2012cites this paper
• Solifenacin objectively decreases urinary sensation in women with overactive bladder syndrome

  2012cites this paper
• Clinical trials and overactive bladder: lessons learned

  2012cites this paper
• Overactive bladder, differential diagnosis, and clinical utility of fesoterodine

  2012cites this paper
• Pathophysiology of Overactive Bladder

  2012cites this paper
• Muscarinic agonists and antagonists: effects on the urinary bladder.

  2012cites this paper
• Effects of mirabegron, a novel β3-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin.

  2012cites this paper
• Pharmacologic Management of Lower Urinary Tract Storage and Emptying Failure

  2012cites this paper
• Review: Clinical Trial Outcomes

  2012cites this paper
• Cholinergic signalling pathways in the superficial layers of the human bladder : comparing health, detrusor overactivity and the effect of Botulinum Toxin Type A

  2011cites this paper
• Glycosaminoglycan Therapy for Bladder Diseases: Emerging New Treatments

  2011cites this paper
• Antimuscarinic mechanisms and the overactive detrusor: an update.

  2011cites this paper
• Afferent signaling from the bladder: Species differences evident from extracellular recordings of pelvic and hypogastric nerves

  2011cites this paper
• Comparison of the effects of oestrogen deficiency and old age on primary bladder afferent activity and voiding behaviour in the ageing female rat

  2011cites this paper
• Researching bladder afferents—determining the effects of β3‐adrenergic receptor agonists and botulinum toxin type‐A

  2011cites this paper
• Comparative Analysis of the Effects of Antimuscarinic Agents on Bladder Functions in Both Nonhuman Primates and Rodents

  2011cites this paper
• Drugs and future candidates.

  2011cites this paper
• Muscarinic acetylcholine receptors in the urinary tract.

  2011cites this paper
• Changes in bladder innervation in a mouse model of Alzheimer's disease.

  2010cites this paper
• Investigating afferent nerve activity from the lower urinary tract: Highlighting some basic research techniques and clinical evaluation methods

  2010cites this paper
• Muscarinic acetylcholine receptor subtypes expressed by mouse bladder afferent neurons.

  2010cites this paper
• Words of wisdom. Re: Spontaneous release of acetylcholine from autonomic nerves in the bladder.

  2010cites this paper
• Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity

  2010cites this paper
• Urodynamics in the Evaluation of Overactive Bladder

  2010cites this paper
• Muscarinic Receptor Antagonists, the Overactive Bladder and Efficacy against Urinary Urgency

  2010cites this paper
• Recent advances in the development of antimuscarinic agents for overactive bladder.

  2010cites this paper
• Pharmacological and genetic analysis of mechanisms underlying detrusor overactivity in rats

  2010cites this paper
• The inhibitory role of acetylcholine and muscarinic receptors in bladder afferent activity.

  2010cites this paper
• Tolterodine causes measurable restoration of urethral sensation in women with urge urinary incontinence

  2010cites this paper
• A New Method for Urinary Bladder Hyperactivity in Conscious Rats

  2010cites this paper
• Afferent nerve distribution in the bladder wall of young mice.

  2010cites this paper
• The effects of sacral acupuncture on acetic acid-induced bladder irritation in conscious rats.

  2010cites this paper
• Correlation between pharmacologically-induced changes in cystometric parameters and spinal c-Fos expression in rats.

  2010cites this paper
• Detrusor myocyte activity and afferent signaling

  2010cites this paper
• Effects of phenazopyridine on rat bladder primary afferent activity, and comparison with lidocaine and acetaminophen

  2010cites this paper
• Pelvic Organ Dysfunction in Neurological Disease: Neurological control of the bladder in health and disease

  2010cites this paper
• Effect of long-term oxybutynin administration on c-Fos expression in spinal neurons: inhibition of antimuscarinics on bladder afferents in conscious rats.

  2009cites this paper
• Basic mechanisms of urgency: preclinical and clinical evidence.

  2009cites this paper
• Effect of nicotine on the pelvic afferent nerve activity and bladder pressure in rats

  2009cites this paper
• Proof of principle: The effect of antimuscarinics on bladder filling sensations in healthy subjects—A placebo controlled double blind investigation using 4 and 8 mg tolterodine extended release

  2009cites this paper
• Comparison of Receptor Binding Characteristics of Commonly Used Muscarinic Antagonists in Human Bladder Detrusor and Mucosa

  2009cites this paper
• Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence

  2009cites this paper
• Antimuscarinics and overactive bladder: other mechanism of action

  2009influential citation
• Effects of Propiverine and Its Metabolite Propiverine-N-Oxide on Bladder Contraction and Salivation in Mini Pigs

  2008cites this paper
• Urothelial effects of oral agents for overactive bladder

  2008cites this paper
• Pharmacologic evaluation of pressor and visceromotor reflex responses to bladder distension

  2008cites this paper
• Comparison of perception threshold testing and thermal‐vibratory testing

  2008cites this paper
• Urgency in overactive bladder: translating experimental data into clinical practice.

  2008cites this paper
• Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin

  2008cites this paper
• LUTS treatment: Future treatment options

  2007cites this paper
• Muscarinic receptor antagonists for overactive bladder

  2007cites this paper
• Propriétés pharmacologiques de l’oxybutynine sur la fonction vésicale chez la souris

  2007cites this paper
• Muscarinic receptors: What we know

  2007cites this paper
• Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve.

  2007cites this paper
• Does tolterodine extended release affect the bladder electrical perception threshold? A placebo controlled, double-blind study with 4 and 8 mg in healthy volunteers.

  2007cites this paper
• Cost implications of antimuscarinic drugs in the treatment of overactive bladder syndrome

  2006cites this paper
• Orale Anticholinergika bei überaktiver Blase

  2006cites this paper
• [Oral anticholinergics in overactive bladder].

  2006cites this paper
• Solifenacin: a new drug for the treatment of overactive bladder and detrusor overactivity

  2006cites this paper
• CELL BIOLOGY

  2005cites this paper
• Open Access Journal of Urology Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Dovepress Role of Fesoterodine in the Treatment of Overactive Bladder

  year unknowncites this paper